Drugs that contain Chlorpheniramine Maleate; Codeine Phosphate

1. List of Tuxarin Er drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9066942 MAINPOINTE Oral dosage forms for oxygen-containing active agents and oxyl-containing polymer
Jan, 2032

(8 years from now)

US9107921 MAINPOINTE Oral dosage forms for oxygen containing active agents and oxyl-containing polymers
Jan, 2032

(8 years from now)

Do you want to check out TUXARIN ER patents from before 2022?

Market Authorisation Date: 22 June, 2015

Treatment: Treatment of cough and symptoms associated with upper respiratory allergies or a common cold with codeine phosphate and chlorpheniramine maleate orally administered extended release tablets


More Information on Dosage

TUXARIN ER family patents


United States

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic